United States · FDA National Drug Code directory
Lovenox
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0075-0626_cdb74d6d-1a74-4156-a52a-710c55cb2927
- Product NDC
- 0075-0626
- Form
- INJECTION
- Composition / generic term
- enoxaparin sodium
- Labeler
- Sanofi-Aventis U.S. LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 19930329
- Source listing expiry
- 20271231
Source-listed ingredients
- ENOXAPARIN SODIUM — 300 mg/3mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, MULTI-DOSE in 1 CARTON (0075-0626-03) / 3 mL in 1 VIAL, MULTI-DOSE · 0075-0626-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →